Loftus, Peter - NewsBios Bio Profile 05-10-10 (DJNS)
Beat: Pharmaceuticals, Biotech and Health
Excerpt: Peter Loftus, 40, has been and remains a prolific generator of news items for the wire service and paper. His total byline count over the past year, including intraday updates, runs into the hundreds. For the print and online editions of the Journal alone, he has written or contributed to about 115 articles.
Based in Philadelphia, Mr. Loftus often writes the “first draft” of news items concerning major pharmaceutical companies, including Pfizer, Merck, Bristol-Myers, Johnson and Johnson, Abbott Laboratories, Eli Lilly, Novartis and Sanofi, among others.
Full dossier on Peter Loftus of Dow Jones Newswires and The Wall Street Journal is 8,998 words in length. Professionally reported and fact-checked. Most recently updated 05/10/10. Includes earlier iterations.
NewsBios aggregates and sifts information from more than 60 sources of public information and combines that research with its own analytics and proprietary databases. Among the core advantages of a NewsBio when compared with an authorized profile is the inclusion of biographical information that journalists do not wish the public to know.
Our research often turns up unauthorized information that may include previous jobs that did not work out well, complaints pertaining to a journalist's reporting, personal life developments that may influence a reporter's news judgment and opinions writers and editors have expressed that reveal a potential bias.
In addition, because NewsBios has prepared more than 10,000 reporter dossiers over a period of two decades, including those on more than 7,000 active journalists, NewsBios is able to put individual bios in perspective with professional standards in general.
Keywords: NewsBios, Profiles, Biographies, Bios, Dossiers, Journalists, Reporters, Editors, Writers, Authors, Producers, Anchors, Freelance.
Visit NewsBios.com for access to more than 7,000 journalist dossiers.
Excerpt: Peter Loftus, 40, has been and remains a prolific generator of news items for the wire service and paper. His total byline count over the past year, including intraday updates, runs into the hundreds. For the print and online editions of the Journal alone, he has written or contributed to about 115 articles.
Based in Philadelphia, Mr. Loftus often writes the “first draft” of news items concerning major pharmaceutical companies, including Pfizer, Merck, Bristol-Myers, Johnson and Johnson, Abbott Laboratories, Eli Lilly, Novartis and Sanofi, among others.
Full dossier on Peter Loftus of Dow Jones Newswires and The Wall Street Journal is 8,998 words in length. Professionally reported and fact-checked. Most recently updated 05/10/10. Includes earlier iterations.
NewsBios aggregates and sifts information from more than 60 sources of public information and combines that research with its own analytics and proprietary databases. Among the core advantages of a NewsBio when compared with an authorized profile is the inclusion of biographical information that journalists do not wish the public to know.
Our research often turns up unauthorized information that may include previous jobs that did not work out well, complaints pertaining to a journalist's reporting, personal life developments that may influence a reporter's news judgment and opinions writers and editors have expressed that reveal a potential bias.
In addition, because NewsBios has prepared more than 10,000 reporter dossiers over a period of two decades, including those on more than 7,000 active journalists, NewsBios is able to put individual bios in perspective with professional standards in general.
Keywords: NewsBios, Profiles, Biographies, Bios, Dossiers, Journalists, Reporters, Editors, Writers, Authors, Producers, Anchors, Freelance.
Visit NewsBios.com for access to more than 7,000 journalist dossiers.
- Item #: LoPe102108
